Why Oregon Gave Dental PE a Free Pass — And What It Means for DSO Strategy

Deep Dive #16 — March 11, 2026

Oregon enacted the nation's toughest restrictions on private equity in healthcare. Then it deliberately exempted dental.

SB 951, signed by Governor Kotek in July 2025, prohibits management services organizations from owning or controlling a majority interest in the medical practices they manage. It bans noncompete agreements for employed physicians unless they hold at least 10% equity. It voids nondisclosure clauses that would prevent doctors from reporting patient safety concerns. The law applies to physicians, nurse practitioners, physician associates, and naturopathic practitioners — and it became operative for new MSOs on January 1, 2026, with existing MSOs required to comply by January 1, 2029.

But buried in the statute is a three-word carve-out that changes everything for dental: "does not apply to dental, veterinary, or optometry practices." The exemption is explicit and unconditional. Kirkland & Ellis's analysis confirms the scope is limited to physician-led practices. Dental PE consolidation in Oregon faces zero new restrictions under SB 951.

What Happened

SB 951 emerged from a growing national backlash against private equity in healthcare, catalyzed by the $9 billion collapse of Steward Health Care — a PE-backed hospital chain that left communities without emergency departments and nurses without paychecks. Oregon legislators, led by Senator Deb Patterson's Health Care Committee, moved aggressively to restrict the MSO model that PE firms use to exert operational control over medical practices while technically preserving physician ownership on paper.

The law's provisions are sweeping. MSOs and their affiliates cannot own or control a majority interest in the medical practice. Noncompete agreements are banned for employed physicians unless they hold at least 10% equity. Nondisclosure clauses that would prevent doctors from reporting safety concerns are voided. And critically, the law requires transparency in MSO-practice financial relationships that PE firms have traditionally kept opaque.

Yet dental was carved out. The reason is structural: Oregon regulates medicine and dentistry under entirely separate statutory chapters. SB 951 amends ORS 58.375, which governs medical corporations. Dental practice is governed by ORS 679.020, which already requires a licensed dentist to own, operate, and maintain any dental practice — with a narrow exception allowing non-dentists to manage "business aspects" that don't include clinical practice. That exception is the legal foundation for every DSO operating in Oregon today. Legislators treated the two regimes as separate problems rather than merging them.

The political energy behind SB 951 came from physician advocacy groups and the AMA, which has since profiled the law as a model for its national campaign against corporate medicine. The Oregon Dental Association was silent — neither supporting nor opposing the bill. Oregon's dental landscape — dominated by Advantage Dental (55+ offices, DentaQuest/Sun Life), Willamette Dental Group (90+ providers), and national chains including Heartland Dental (KKR), Aspen Dental (TAG), and Pacific Dental Services — was simply not in the crosshairs.

California took the opposite approach. SB 351, signed in October 2025, explicitly covers "physician and dental practices" — barring PE firms from imposing patient quotas, restricting procedure types, or interfering in clinical referrals for both physicians and dentists. The California Dental Association co-sponsored the bill. Oregon's exclusion and California's inclusion of dental are now the two competing models for every other state considering similar legislation.

The Risks

The exemption creates a two-tier regulatory environment in Oregon. Physician practices face strict MSO control limits; dental practices face none. This asymmetry has three implications:

First, it may accelerate dental consolidation in Oregon. PE firms facing new restrictions in physician markets may redirect capital into dental, where the MSO model operates without constraints. The numbers are already moving: PE affiliation among dentists nearly doubled from 6.6% in 2015 to 12.8% in 2021. Dental had the highest PE deal activity of any healthcare category in 2024 (161 deals) and second-highest in 2025 (149 deals), with 95% being add-on acquisitions. Our Deal Tracker shows 9 dental acquisitions in Oregon since 2023, with deal velocity increasing — 1 in 2023, 3 in 2024, 4 in 2025, and 1 already in 2026. Oregon's regulatory environment just became comparatively more attractive for dental PE deployment.

Second, the evidence of post-acquisition behavior change is growing. A 2026 study in Health Services Research — titled "Financial Incisors" — found that dental offices raised charges by 3.3% following PE acquisition and shifted their procedure mix toward higher-reimbursement restorative and surgical services. This is exactly the kind of evidence that fueled California's decision to include dental in its restrictions. If similar patterns emerge in Oregon's growing DSO market, the exemption becomes politically untenable.

Third, the exemption may not hold. If a DSO-related patient care controversy emerges in Oregon — a billing scandal, a quality failure, a workforce dispute — legislators will face pressure to close the carve-out. The PeaceHealth-ApolloMD dispute in Lane County (a physician staffing controversy) is already testing SB 951's enforcement. A dental equivalent would put the exemption on the 2027 long session agenda immediately.

Fourth, the national precedent matters. At least 15 states have active PE healthcare restriction legislation, including Washington, New York, Connecticut, Colorado, and Minnesota. Whether those states follow Oregon's model (exclude dental) or California's (include dental) will shape the regulatory landscape for DSO investment nationally. California's CDA co-sponsored the inclusion; Oregon's ODA was silent. That silence is a choice that other state dental associations are watching.

The Opportunity

For dental practice owners in Oregon, the exemption is a window — but windows close.

Sellers have leverage now. Oregon's regulatory clarity (dental is explicitly unrestricted) makes the state more attractive to PE-backed DSOs than states with ambiguous corporate practice of medicine doctrines. Practice owners exploring a sale can point to the stable regulatory environment as a de-risking factor. Our data shows Imagen Dental Partners, SALT Dental Partners, MB2 Dental (Revelstoke Capital), and Heartland Dental (KKR) are all active acquirers in Oregon.

DSOs can operate without restructuring. Unlike physician MSOs, which must now unwind majority ownership positions and restructure governance by January 2029, dental MSOs in Oregon face no compliance burden. This operational certainty has real value — compliance costs for physician MSOs are estimated at $50,000-$200,000 per practice depending on complexity.

The 2027 long session is the horizon. Oregon's next legislative session opens in January 2027. If the dental exemption survives that session without challenge, it signals durable regulatory stability. Practice owners considering a sale in the next 12-18 months have the clearest regulatory picture in the country.

Action Items

1. Practice owners considering a sale: Move your timeline forward. Oregon's explicit dental PE exemption is a selling point today, but it may not survive the 2027 session if dental consolidation draws scrutiny. Get your financials clean, your EBITDA margins documented, and your patient retention metrics ready.
2. DSOs expanding in Oregon: Document your governance model and clinical quality metrics now. If the exemption is challenged, having a track record of quality outcomes and provider satisfaction will be your best defense against regulatory expansion.
3. Practice owners staying independent: Understand that the competitive landscape is tilting further toward consolidation. Oregon's regulatory environment actively favors DSOs over independent practices in ways that physician practices no longer enjoy. Invest in your competitive advantages — patient relationships, community roots, specialized services — that DSOs struggle to replicate.
4. Policy watchers: Track HB 4040 (dental claims timelines, awaiting Kotek's signature, operative January 2028) and HB 4039 (CCO rate transparency). These bills signal that legislators are paying attention to dental economics even if SB 951 didn't touch PE consolidation directly.
5. Dental industry groups (ODA, ADA): Consider proactively proposing quality standards or voluntary governance principles for DSOs in Oregon. The best way to preserve the exemption is to demonstrate that dental PE doesn't need the same restrictions as physician PE. The worst outcome is waiting for a crisis to force the conversation.

Bottom Line

Oregon drew a bright line: physician PE is restricted, dental PE is not. That line creates a 12-18 month window of regulatory clarity that benefits sellers, acquirers, and operators. But the exemption is a political choice, not a permanent guarantee. The practices, DSOs, and PE firms that move strategically now — while the door is explicitly open — will be better positioned than those who assume it stays open forever. In healthcare regulation, carve-outs are borrowed time.

Sources: Kirkland & Ellis SB 951 Analysis, Nixon Peabody SB 951 Explainer, AMA Corporate Medicine Profile, CDA on California SB 351, Health Affairs PE Affiliation Study, "Financial Incisors" — Health Services Research 2026, PESP PE Healthcare Deals 2025, AFT/Steward Health Care Report, Source on Healthcare CPOM Tracker, ORS 679.020 Practice of Dentistry, Praxis AI Deal Tracker (3,273 deals, 871 dental). Oregon Legislative Assembly 2025 Session, SB 951 enrolled bill. Data current as of March 11, 2026.